JP2005503327A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005503327A5 JP2005503327A5 JP2002564480A JP2002564480A JP2005503327A5 JP 2005503327 A5 JP2005503327 A5 JP 2005503327A5 JP 2002564480 A JP2002564480 A JP 2002564480A JP 2002564480 A JP2002564480 A JP 2002564480A JP 2005503327 A5 JP2005503327 A5 JP 2005503327A5
- Authority
- JP
- Japan
- Prior art keywords
- methoxy
- isophthalamide
- benzyl
- ylmethyl
- benzodioxol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- -1 (4-carboxyphenyl) methyl Chemical group 0.000 claims description 6
- 229910052739 hydrogen Inorganic materials 0.000 claims 11
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims 10
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 claims 10
- 150000003839 salts Chemical class 0.000 claims 9
- 102100027995 Collagenase 3 Human genes 0.000 claims 7
- 108050005238 Collagenase 3 Proteins 0.000 claims 7
- 125000005843 halogen group Chemical group 0.000 claims 7
- 239000001257 hydrogen Substances 0.000 claims 7
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims 7
- 229940125532 enzyme inhibitor Drugs 0.000 claims 6
- 239000002532 enzyme inhibitor Substances 0.000 claims 6
- 125000004356 hydroxy functional group Chemical group O* 0.000 claims 6
- 125000001072 heteroaryl group Chemical group 0.000 claims 5
- 229910052760 oxygen Inorganic materials 0.000 claims 5
- 229910052717 sulfur Inorganic materials 0.000 claims 5
- 125000003118 aryl group Chemical group 0.000 claims 4
- 229910052799 carbon Inorganic materials 0.000 claims 4
- 150000001875 compounds Chemical class 0.000 claims 4
- 125000000753 cycloalkyl group Chemical group 0.000 claims 4
- 125000005842 heteroatom Chemical group 0.000 claims 4
- 229910052757 nitrogen Inorganic materials 0.000 claims 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 4
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims 4
- DLJHGFRDZJNAOW-UHFFFAOYSA-N 1-n,3-n-bis(1,3-benzodioxol-5-ylmethyl)-4-ethoxybenzene-1,3-dicarboxamide Chemical compound C1=C2OCOC2=CC(CNC(=O)C2=CC=C(C(=C2)C(=O)NCC=2C=C3OCOC3=CC=2)OCC)=C1 DLJHGFRDZJNAOW-UHFFFAOYSA-N 0.000 claims 3
- BWXMKQAFGBOUJS-UHFFFAOYSA-N 1-n-(1,3-benzodioxol-5-ylmethyl)-4-methoxy-3-n-[(4-methoxyphenyl)methyl]benzene-1,3-dicarboxamide Chemical compound C1=CC(OC)=CC=C1CNC(=O)C1=CC(C(=O)NCC=2C=C3OCOC3=CC=2)=CC=C1OC BWXMKQAFGBOUJS-UHFFFAOYSA-N 0.000 claims 3
- YMPIVIUZLXRGTO-UHFFFAOYSA-N 1-n,3-n-bis(1,3-benzodioxol-5-ylmethyl)-4-propan-2-yloxybenzene-1,3-dicarboxamide Chemical compound C1=C2OCOC2=CC(CNC(=O)C2=CC=C(C(=C2)C(=O)NCC=2C=C3OCOC3=CC=2)OC(C)C)=C1 YMPIVIUZLXRGTO-UHFFFAOYSA-N 0.000 claims 2
- ZOXUBJQLTFTSCN-UHFFFAOYSA-N 1-n,3-n-bis[(4-fluoro-3-methoxyphenyl)methyl]benzene-1,3-dicarboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2C=C(C=CC=2)C(=O)NCC=2C=C(OC)C(F)=CC=2)=C1 ZOXUBJQLTFTSCN-UHFFFAOYSA-N 0.000 claims 2
- BUBYRGGBUUPUKP-UHFFFAOYSA-N 1-n-(1,3-benzodioxol-5-ylmethyl)-3-n-(pyridin-3-ylmethyl)benzene-1,3-dicarboxamide Chemical compound C=1C=CC(C(=O)NCC=2C=C3OCOC3=CC=2)=CC=1C(=O)NCC1=CC=CN=C1 BUBYRGGBUUPUKP-UHFFFAOYSA-N 0.000 claims 2
- UVZKYRQQLQNVIW-UHFFFAOYSA-N 1-n-(1,3-benzodioxol-5-ylmethyl)-3-n-[(4-chlorophenyl)methyl]-4-methoxybenzene-1,3-dicarboxamide Chemical compound COC1=CC=C(C(=O)NCC=2C=C3OCOC3=CC=2)C=C1C(=O)NCC1=CC=C(Cl)C=C1 UVZKYRQQLQNVIW-UHFFFAOYSA-N 0.000 claims 2
- JTOPDTSXSUFWAE-UHFFFAOYSA-N 1-n-(1,3-benzodioxol-5-ylmethyl)-4-methoxy-3-n-(2-phenoxyethyl)benzene-1,3-dicarboxamide Chemical compound COC1=CC=C(C(=O)NCC=2C=C3OCOC3=CC=2)C=C1C(=O)NCCOC1=CC=CC=C1 JTOPDTSXSUFWAE-UHFFFAOYSA-N 0.000 claims 2
- ATCZYCZXMHDUCY-UHFFFAOYSA-N 1-n-[(3-methoxyphenyl)methyl]-3-n-(pyridin-3-ylmethyl)benzene-1,3-dicarboxamide Chemical compound COC1=CC=CC(CNC(=O)C=2C=C(C=CC=2)C(=O)NCC=2C=NC=CC=2)=C1 ATCZYCZXMHDUCY-UHFFFAOYSA-N 0.000 claims 2
- LMLNFKWOZIDESX-UHFFFAOYSA-N 1-n-[(4-chlorophenyl)methyl]-3-n-[(3-methoxyphenyl)methyl]benzene-1,3-dicarboxamide Chemical compound COC1=CC=CC(CNC(=O)C=2C=C(C=CC=2)C(=O)NCC=2C=CC(Cl)=CC=2)=C1 LMLNFKWOZIDESX-UHFFFAOYSA-N 0.000 claims 2
- VYOCZSSYBSYYDC-UHFFFAOYSA-N 1-n-benzyl-4-methoxy-3-n-(2-phenoxyethyl)benzene-1,3-dicarboxamide Chemical compound COC1=CC=C(C(=O)NCC=2C=CC=CC=2)C=C1C(=O)NCCOC1=CC=CC=C1 VYOCZSSYBSYYDC-UHFFFAOYSA-N 0.000 claims 2
- NNFZVGZCQAFYRD-UHFFFAOYSA-N 1-n-benzyl-4-methoxy-3-n-[(4-methoxyphenyl)methyl]benzene-1,3-dicarboxamide Chemical compound C1=CC(OC)=CC=C1CNC(=O)C1=CC(C(=O)NCC=2C=CC=CC=2)=CC=C1OC NNFZVGZCQAFYRD-UHFFFAOYSA-N 0.000 claims 2
- NZUZSTGQWDUOON-UHFFFAOYSA-N 3-n-(1,3-benzodioxol-5-ylmethyl)-1-n-(2-ethoxyethyl)-4-methoxybenzene-1,3-dicarboxamide Chemical compound CCOCCNC(=O)C1=CC=C(OC)C(C(=O)NCC=2C=C3OCOC3=CC=2)=C1 NZUZSTGQWDUOON-UHFFFAOYSA-N 0.000 claims 2
- IOJFPRFJQCNQBB-UHFFFAOYSA-N 3-n-(1,3-benzodioxol-5-ylmethyl)-4-methoxy-1-n-(2-phenoxyethyl)benzene-1,3-dicarboxamide Chemical compound C1=C(C(=O)NCC=2C=C3OCOC3=CC=2)C(OC)=CC=C1C(=O)NCCOC1=CC=CC=C1 IOJFPRFJQCNQBB-UHFFFAOYSA-N 0.000 claims 2
- YUCYBYUNQNZMOD-UHFFFAOYSA-N 3-n-[(3,4-dichlorophenyl)methyl]-1-n-(pyridin-4-ylmethyl)benzene-1,3-dicarboxamide Chemical compound C1=C(Cl)C(Cl)=CC=C1CNC(=O)C1=CC=CC(C(=O)NCC=2C=CN=CC=2)=C1 YUCYBYUNQNZMOD-UHFFFAOYSA-N 0.000 claims 2
- FTCLLFQMNSZUMY-UHFFFAOYSA-N 3-n-[(3,4-dichlorophenyl)methyl]-1-n-[(3-methoxyphenyl)methyl]benzene-1,3-dicarboxamide Chemical compound COC1=CC=CC(CNC(=O)C=2C=C(C=CC=2)C(=O)NCC=2C=C(Cl)C(Cl)=CC=2)=C1 FTCLLFQMNSZUMY-UHFFFAOYSA-N 0.000 claims 2
- HHONLJVHEDKNSH-UHFFFAOYSA-N 3-n-[(3-methoxyphenyl)methyl]-1-n-(pyridin-4-ylmethyl)benzene-1,3-dicarboxamide Chemical compound COC1=CC=CC(CNC(=O)C=2C=C(C=CC=2)C(=O)NCC=2C=CN=CC=2)=C1 HHONLJVHEDKNSH-UHFFFAOYSA-N 0.000 claims 2
- AYHWNJYLWMCQRL-UHFFFAOYSA-N 3-n-[(3-methoxyphenyl)methyl]-1-n-[(4-methoxyphenyl)methyl]benzene-1,3-dicarboxamide Chemical compound C1=CC(OC)=CC=C1CNC(=O)C1=CC=CC(C(=O)NCC=2C=C(OC)C=CC=2)=C1 AYHWNJYLWMCQRL-UHFFFAOYSA-N 0.000 claims 2
- DELRPQVRQQZQGJ-UHFFFAOYSA-N 3-n-[(3-methoxyphenyl)methyl]-1-n-[(4-nitrophenyl)methyl]benzene-1,3-dicarboxamide Chemical compound COC1=CC=CC(CNC(=O)C=2C=C(C=CC=2)C(=O)NCC=2C=CC(=CC=2)[N+]([O-])=O)=C1 DELRPQVRQQZQGJ-UHFFFAOYSA-N 0.000 claims 2
- FSCMLHMAYBLEAH-UHFFFAOYSA-N 4-[[[3-[(3-methoxyphenyl)methylcarbamoyl]benzoyl]amino]methyl]benzoic acid Chemical compound COC1=CC=CC(CNC(=O)C=2C=C(C=CC=2)C(=O)NCC=2C=CC(=CC=2)C(O)=O)=C1 FSCMLHMAYBLEAH-UHFFFAOYSA-N 0.000 claims 2
- ZVAWHZJJYVYLMF-UHFFFAOYSA-N 4-methoxy-1-n,3-n-bis[(4-methoxyphenyl)methyl]benzene-1,3-dicarboxamide Chemical compound C1=CC(OC)=CC=C1CNC(=O)C1=CC=C(OC)C(C(=O)NCC=2C=CC(OC)=CC=2)=C1 ZVAWHZJJYVYLMF-UHFFFAOYSA-N 0.000 claims 2
- TWGGNMLHTLYBCJ-UHFFFAOYSA-N 4-methoxy-1-n-[(4-methoxyphenyl)methyl]-3-n-(pyridin-4-ylmethyl)benzene-1,3-dicarboxamide Chemical compound C1=CC(OC)=CC=C1CNC(=O)C1=CC=C(OC)C(C(=O)NCC=2C=CN=CC=2)=C1 TWGGNMLHTLYBCJ-UHFFFAOYSA-N 0.000 claims 2
- BZPPRYGDVUMPML-UHFFFAOYSA-N 5-[bis(2,1,3-benzothiadiazol-5-yl)methoxycarbonyl]-2-methoxybenzoic acid Chemical compound C1=C(C(O)=O)C(OC)=CC=C1C(=O)OC(C1=CC2=NSN=C2C=C1)C1=CC2=NSN=C2C=C1 BZPPRYGDVUMPML-UHFFFAOYSA-N 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- MHEIZFPOUPPIFS-UHFFFAOYSA-N methyl 4-[[[3-[(3-methoxyphenyl)methylcarbamoyl]benzoyl]amino]methyl]benzoate Chemical compound C1=CC(C(=O)OC)=CC=C1CNC(=O)C1=CC=CC(C(=O)NCC=2C=C(OC)C=CC=2)=C1 MHEIZFPOUPPIFS-UHFFFAOYSA-N 0.000 claims 2
- SXPXDKZEMLOBMI-UHFFFAOYSA-N 1-n,3-n-bis(1,3-benzodioxol-5-ylmethyl)-4-methoxybenzene-1,3-dicarboxamide Chemical compound C1=C2OCOC2=CC(CNC(=O)C2=CC=C(C(=C2)C(=O)NCC=2C=C3OCOC3=CC=2)OC)=C1 SXPXDKZEMLOBMI-UHFFFAOYSA-N 0.000 claims 1
- ARFDIYXVMUTGOD-UHFFFAOYSA-N 1-n,3-n-bis(1,3-benzodioxol-5-ylmethyl)-4-propoxybenzene-1,3-dicarboxamide Chemical compound C1=C2OCOC2=CC(CNC(=O)C2=CC=C(C(=C2)C(=O)NCC=2C=C3OCOC3=CC=2)OCCC)=C1 ARFDIYXVMUTGOD-UHFFFAOYSA-N 0.000 claims 1
- KPEAXRIRNHOZRN-UHFFFAOYSA-N 1-n,3-n-bis(2,1,3-benzothiadiazol-5-ylmethyl)-4-methoxybenzene-1,3-dicarboxamide Chemical compound C1=CC2=NSN=C2C=C1CNC(=O)C1=CC=C(OC)C(C(=O)NCC2=CC3=NSN=C3C=C2)=C1 KPEAXRIRNHOZRN-UHFFFAOYSA-N 0.000 claims 1
- YRAKHPVRCLNZOJ-UHFFFAOYSA-N 1-n,3-n-bis[(3-fluorophenyl)methyl]benzene-1,3-dicarboxamide Chemical compound FC1=CC=CC(CNC(=O)C=2C=C(C=CC=2)C(=O)NCC=2C=C(F)C=CC=2)=C1 YRAKHPVRCLNZOJ-UHFFFAOYSA-N 0.000 claims 1
- FDHRHFFGUMUTPU-UHFFFAOYSA-N 1-n,3-n-bis[(3-methoxyphenyl)methyl]-4-propan-2-yloxybenzene-1,3-dicarboxamide Chemical compound COC1=CC=CC(CNC(=O)C=2C=C(C(OC(C)C)=CC=2)C(=O)NCC=2C=C(OC)C=CC=2)=C1 FDHRHFFGUMUTPU-UHFFFAOYSA-N 0.000 claims 1
- VWTOTPXTUCLZOO-UHFFFAOYSA-N 1-n,3-n-bis[3-(hydroxymethyl)phenyl]benzene-1,3-dicarboxamide Chemical compound OCC1=CC=CC(NC(=O)C=2C=C(C=CC=2)C(=O)NC=2C=C(CO)C=CC=2)=C1 VWTOTPXTUCLZOO-UHFFFAOYSA-N 0.000 claims 1
- ZHWKYWYCCJLPMB-UHFFFAOYSA-N 1-n-(1,3-benzodioxol-5-ylmethyl)-3-n-(furan-2-ylmethyl)benzene-1,3-dicarboxamide Chemical compound C=1C=CC(C(=O)NCC=2C=C3OCOC3=CC=2)=CC=1C(=O)NCC1=CC=CO1 ZHWKYWYCCJLPMB-UHFFFAOYSA-N 0.000 claims 1
- MUHDVDRIJBHMAF-UHFFFAOYSA-N 1-n-[(3-aminophenyl)methyl]-3-n-[(3-methoxyphenyl)methyl]benzene-1,3-dicarboxamide Chemical compound COC1=CC=CC(CNC(=O)C=2C=C(C=CC=2)C(=O)NCC=2C=C(N)C=CC=2)=C1 MUHDVDRIJBHMAF-UHFFFAOYSA-N 0.000 claims 1
- JHNVFWVRLLKMOB-UHFFFAOYSA-N 1-n-[(3-methoxyphenyl)methyl]-3-n-[[3-(trifluoromethoxy)phenyl]methyl]benzene-1,3-dicarboxamide Chemical compound COC1=CC=CC(CNC(=O)C=2C=C(C=CC=2)C(=O)NCC=2C=C(OC(F)(F)F)C=CC=2)=C1 JHNVFWVRLLKMOB-UHFFFAOYSA-N 0.000 claims 1
- PWRFOQUTHYMTDU-UHFFFAOYSA-N 3-(1,3-benzodioxol-5-ylmethylcarbamoyl)benzoic acid Chemical compound OC(=O)C1=CC=CC(C(=O)NCC=2C=C3OCOC3=CC=2)=C1 PWRFOQUTHYMTDU-UHFFFAOYSA-N 0.000 claims 1
- RQUSCWRVJBYBPO-UHFFFAOYSA-N 3-n-(1,3-benzodioxol-5-ylmethyl)-4-methoxy-1-n-[(4-methoxyphenyl)methyl]benzene-1,3-dicarboxamide Chemical compound C1=CC(OC)=CC=C1CNC(=O)C1=CC=C(OC)C(C(=O)NCC=2C=C3OCOC3=CC=2)=C1 RQUSCWRVJBYBPO-UHFFFAOYSA-N 0.000 claims 1
- GTFWIWOIASOPQL-UHFFFAOYSA-N 3-n-[(3-methoxyphenyl)methyl]-1-n-[(3-nitrophenyl)methyl]benzene-1,3-dicarboxamide Chemical compound COC1=CC=CC(CNC(=O)C=2C=C(C=CC=2)C(=O)NCC=2C=C(C=CC=2)[N+]([O-])=O)=C1 GTFWIWOIASOPQL-UHFFFAOYSA-N 0.000 claims 1
- ZZEIJCGKNSSFKK-UHFFFAOYSA-N 3-n-[(3-methoxyphenyl)methyl]-1-n-[(4-methylphenyl)methyl]benzene-1,3-dicarboxamide Chemical compound COC1=CC=CC(CNC(=O)C=2C=C(C=CC=2)C(=O)NCC=2C=CC(C)=CC=2)=C1 ZZEIJCGKNSSFKK-UHFFFAOYSA-N 0.000 claims 1
- WUXHHRNMOXVIJG-UHFFFAOYSA-N 3-n-benzyl-4-methoxy-1-n-[(4-methoxyphenyl)methyl]benzene-1,3-dicarboxamide Chemical compound C1=CC(OC)=CC=C1CNC(=O)C1=CC=C(OC)C(C(=O)NCC=2C=CC=CC=2)=C1 WUXHHRNMOXVIJG-UHFFFAOYSA-N 0.000 claims 1
- COEQEZQJWZLDRB-UHFFFAOYSA-N 4-acetamido-1-n,3-n-bis(1,3-benzodioxol-5-ylmethyl)benzene-1,3-dicarboxamide Chemical compound C1=C2OCOC2=CC(CNC(=O)C2=CC=C(C(=C2)C(=O)NCC=2C=C3OCOC3=CC=2)NC(=O)C)=C1 COEQEZQJWZLDRB-UHFFFAOYSA-N 0.000 claims 1
- SFONSYDJUULGOH-UHFFFAOYSA-N 4-amino-1-n,3-n-bis(1,3-benzodioxol-5-ylmethyl)benzene-1,3-dicarboxamide Chemical compound C1=C2OCOC2=CC(CNC(=O)C2=CC=C(C(=C2)C(=O)NCC=2C=C3OCOC3=CC=2)N)=C1 SFONSYDJUULGOH-UHFFFAOYSA-N 0.000 claims 1
- VENQEXJDQSPPQG-UHFFFAOYSA-N 4-ethoxy-1-n,3-n-bis[(3-methoxyphenyl)methyl]benzene-1,3-dicarboxamide Chemical compound CCOC1=CC=C(C(=O)NCC=2C=C(OC)C=CC=2)C=C1C(=O)NCC1=CC=CC(OC)=C1 VENQEXJDQSPPQG-UHFFFAOYSA-N 0.000 claims 1
- RRTKUODZKAXDTQ-UHFFFAOYSA-N 4-methoxy-1-n,3-n-bis[(3-methoxyphenyl)methyl]benzene-1,3-dicarboxamide Chemical compound COC1=CC=CC(CNC(=O)C=2C=C(C(OC)=CC=2)C(=O)NCC=2C=C(OC)C=CC=2)=C1 RRTKUODZKAXDTQ-UHFFFAOYSA-N 0.000 claims 1
- GTIZRDCVWFFWDG-UHFFFAOYSA-N 4-methoxy-1-n,3-n-bis[(4-methylphenyl)methyl]benzene-1,3-dicarboxamide Chemical compound COC1=CC=C(C(=O)NCC=2C=CC(C)=CC=2)C=C1C(=O)NCC1=CC=C(C)C=C1 GTIZRDCVWFFWDG-UHFFFAOYSA-N 0.000 claims 1
- 125000004217 4-methoxybenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1OC([H])([H])[H])C([H])([H])* 0.000 claims 1
- OJABIAFLZIQNBM-UHFFFAOYSA-N 5-(dipyridin-4-ylmethoxycarbonyl)-2-methoxybenzoic acid Chemical compound C1=C(C(O)=O)C(OC)=CC=C1C(=O)OC(C=1C=CN=CC=1)C1=CC=NC=C1 OJABIAFLZIQNBM-UHFFFAOYSA-N 0.000 claims 1
- 206010007559 Cardiac failure congestive Diseases 0.000 claims 1
- 102000004190 Enzymes Human genes 0.000 claims 1
- 108090000790 Enzymes Proteins 0.000 claims 1
- 206010019280 Heart failures Diseases 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Substances CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims 1
- 239000000654 additive Substances 0.000 claims 1
- 230000000996 additive effect Effects 0.000 claims 1
- ZWIHVWXPZTVADY-UHFFFAOYSA-N bis[(3-fluorophenyl)methyl] benzene-1,3-dicarboxylate Chemical compound FC1=CC=CC(COC(=O)C=2C=C(C=CC=2)C(=O)OCC=2C=C(F)C=CC=2)=C1 ZWIHVWXPZTVADY-UHFFFAOYSA-N 0.000 claims 1
- CDCXFWZASVOWMR-UHFFFAOYSA-N bis[(3-methoxyphenyl)methyl] benzene-1,3-dicarboxylate Chemical compound COC1=CC=CC(COC(=O)C=2C=C(C=CC=2)C(=O)OCC=2C=C(OC)C=CC=2)=C1 CDCXFWZASVOWMR-UHFFFAOYSA-N 0.000 claims 1
- PKZQNIBSRFWVGL-UHFFFAOYSA-N bis[(4-fluorophenyl)methyl] benzene-1,3-dicarboxylate Chemical compound C1=CC(F)=CC=C1COC(=O)C1=CC=CC(C(=O)OCC=2C=CC(F)=CC=2)=C1 PKZQNIBSRFWVGL-UHFFFAOYSA-N 0.000 claims 1
- VFRFJQKNTSNQLG-UHFFFAOYSA-N bis[(4-methoxyphenyl)methyl] benzene-1,3-dicarboxylate Chemical compound C1=CC(OC)=CC=C1COC(=O)C1=CC=CC(C(=O)OCC=2C=CC(OC)=CC=2)=C1 VFRFJQKNTSNQLG-UHFFFAOYSA-N 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- PIUBIABTWWMYIG-UHFFFAOYSA-N dibenzyl 4-(2-methoxy-2-oxoethoxy)benzene-1,3-dicarboxylate Chemical compound COC(=O)COC1=CC=C(C(=O)OCC=2C=CC=CC=2)C=C1C(=O)OCC1=CC=CC=C1 PIUBIABTWWMYIG-UHFFFAOYSA-N 0.000 claims 1
- ZMVWHFUIHDPEGR-UHFFFAOYSA-N dibenzyl 4-acetylbenzene-1,3-dicarboxylate Chemical compound CC(=O)C1=CC=C(C(=O)OCC=2C=CC=CC=2)C=C1C(=O)OCC1=CC=CC=C1 ZMVWHFUIHDPEGR-UHFFFAOYSA-N 0.000 claims 1
- JZLXKHXOFZYSGI-UHFFFAOYSA-N dibenzyl 4-methoxybenzene-1,3-dicarboxylate Chemical compound COC1=CC=C(C(=O)OCC=2C=CC=CC=2)C=C1C(=O)OCC1=CC=CC=C1 JZLXKHXOFZYSGI-UHFFFAOYSA-N 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 230000001404 mediated effect Effects 0.000 claims 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 1
- 201000008482 osteoarthritis Diseases 0.000 claims 1
- QQVIHTHCMHWDBS-UHFFFAOYSA-N perisophthalic acid Natural products OC(=O)C1=CC=CC(C(O)=O)=C1 QQVIHTHCMHWDBS-UHFFFAOYSA-N 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 206010039073 rheumatoid arthritis Diseases 0.000 claims 1
- 239000007787 solid Substances 0.000 description 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- FDQSRULYDNDXQB-UHFFFAOYSA-N benzene-1,3-dicarbonyl chloride Chemical compound ClC(=O)C1=CC=CC(C(Cl)=O)=C1 FDQSRULYDNDXQB-UHFFFAOYSA-N 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- IIFVWLUQBAIPMJ-UHFFFAOYSA-N (4-fluorophenyl)methanamine Chemical compound NCC1=CC=C(F)C=C1 IIFVWLUQBAIPMJ-UHFFFAOYSA-N 0.000 description 1
- 0 C*c(c(C(OC)=O)c1)c(*)c(*)c1C(O*(C)(C)*)=O Chemical compound C*c(c(C(OC)=O)c1)c(*)c(*)c1C(O*(C)(C)*)=O 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000004454 trace mineral analysis Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US26873601P | 2001-02-14 | 2001-02-14 | |
| PCT/IB2002/000344 WO2002064547A2 (en) | 2001-02-14 | 2002-02-04 | Isophthalic acid derivatives as matrix metalloproteinase inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005503327A JP2005503327A (ja) | 2005-02-03 |
| JP2005503327A5 true JP2005503327A5 (enExample) | 2008-05-29 |
Family
ID=23024241
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002564480A Pending JP2005503327A (ja) | 2001-02-14 | 2002-02-04 | マトリックスメタロプロテイナーゼ阻害剤としてのイソフタル酸誘導体 |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US6995151B2 (enExample) |
| EP (1) | EP1362028A2 (enExample) |
| JP (1) | JP2005503327A (enExample) |
| AR (1) | AR032679A1 (enExample) |
| BR (1) | BR0207201A (enExample) |
| CA (1) | CA2435376A1 (enExample) |
| DO (1) | DOP2002000333A (enExample) |
| MX (1) | MXPA03006598A (enExample) |
| PA (1) | PA8539801A1 (enExample) |
| PE (1) | PE20020859A1 (enExample) |
| TN (1) | TNSN02008A1 (enExample) |
| UY (1) | UY27169A1 (enExample) |
| WO (1) | WO2002064547A2 (enExample) |
Families Citing this family (45)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DOP2002000333A (es) * | 2001-02-14 | 2002-09-30 | Warner Lambert Co | Derivados de acido isoftalico como inhibidores de metaloproteinasas de la matriz |
| DOP2002000332A (es) | 2001-02-14 | 2002-08-30 | Warner Lambert Co | Inhibidores de piridina de metaloproteinasas de la matriz |
| ATE472535T1 (de) | 2001-02-14 | 2010-07-15 | Warner Lambert Co | Pyrimidinmatrixmetalloproteinaseinhibitoren |
| US6924276B2 (en) * | 2001-09-10 | 2005-08-02 | Warner-Lambert Company | Diacid-substituted heteroaryl derivatives as matrix metalloproteinase inhibitors |
| JP4164028B2 (ja) | 2001-10-12 | 2008-10-08 | ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー | アルキンマトリックスメタロプロテイナーゼ阻害剤 |
| US6962922B2 (en) | 2001-10-12 | 2005-11-08 | Warner-Lambert Company Llc | Alkynylated quinazoline compounds |
| DE10160357A1 (de) * | 2001-12-08 | 2003-06-18 | Aventis Pharma Gmbh | Verwendung von Pyridin-2,4-dicarbonsäurediamiden und Pyrimidin-4,6-dicarbonsäurediamiden zur selektiven Inhibierung von Kollagenasen |
| US6894057B2 (en) | 2002-03-08 | 2005-05-17 | Warner-Lambert Company | Oxo-azabicyclic compounds |
| US6747147B2 (en) | 2002-03-08 | 2004-06-08 | Warner-Lambert Company | Oxo-azabicyclic compounds |
| US20040006077A1 (en) * | 2002-06-25 | 2004-01-08 | Bernard Gaudilliere | Thiazine and oxazine derivatives as MMP-13 inhibitors |
| BR0312727A (pt) * | 2002-07-17 | 2005-04-19 | Warner Lambert Co | Combinação de um inibidor alostérico da metaloproteinase-13 de matriz com celecoxib ou valdecoxib |
| EP1534274A1 (en) * | 2002-07-17 | 2005-06-01 | Warner-Lambert Company LLC | Combination of an allosteric alkyne inhibitor of matrix metalloproteinase-13 with celecoxib or valdecoxib |
| JP2006502113A (ja) * | 2002-07-17 | 2006-01-19 | ワーナー−ランバート カンパニー リミティド ライアビリティー カンパニー | マトリックス・メタロプロテイナーゼ−１３アロステリック阻害剤と、セレコキシブ又はバルデコキシブでないシクロオキシゲナーゼ−２選択的阻害剤との複合体 |
| AU2003281169A1 (en) * | 2002-07-17 | 2004-02-02 | Warner-Lambert Company Llc | Combination of an allosteric carboxylic inhibitor of matrix metalloproteinase-13 with celecoxib or valdecoxib |
| EP1530472A1 (en) * | 2002-08-13 | 2005-05-18 | Warner-Lambert Company LLC | Isoquinoline derivatives as matrix metalloproteinase inhibitors |
| WO2004014880A1 (en) | 2002-08-13 | 2004-02-19 | Warner-Lambert Company Llc | Chromone derivatives as matrix metalloproteinase inhibitors |
| EP1394159A1 (fr) * | 2002-08-13 | 2004-03-03 | Warner-Lambert Company LLC | Nouveaux dérivés de thiophène, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent |
| MXPA05001783A (es) | 2002-08-13 | 2005-04-25 | Warner Lambert Co | Derivados de pirimidina-2,4-diona como inhibidores de las metaloproteinasas de matriz. |
| AU2003253186A1 (en) | 2002-08-13 | 2004-02-25 | Warner-Lambert Company Llc | Fused tetrahydropyridine derivatives as matrix metalloproteinase inhibitors |
| WO2004014908A1 (en) * | 2002-08-13 | 2004-02-19 | Warner-Lambert Company Llc | Heterobicylcic metalloproteinase inhibitors |
| AU2003253165A1 (en) * | 2002-08-13 | 2004-02-25 | Warner-Lambert Company Llc | Pyrimidine fused bicyclic metalloproteinase inhibitors |
| AU2003250475A1 (en) * | 2002-08-13 | 2004-02-25 | Warner-Lambert Company Llc | 5,6-fused 3,4-dihydropyrimidine-2-one derivatives as matrix metalloproteinase inhibitors |
| WO2004014365A1 (en) * | 2002-08-13 | 2004-02-19 | Warner-Lambert Company Llc | Phthalimide derivatives as matrix metalloproteinase inhibitors |
| WO2004014378A1 (en) | 2002-08-13 | 2004-02-19 | Warner-Lambert Company Llc | 3-isoquinolinone derivatives as matrix metalloproteinase inhiitors |
| AU2003250470A1 (en) | 2002-08-13 | 2004-02-25 | Warner-Lambert Company Llc | Pyrimidinone fused bicyclic metalloproteinase inhibitors |
| PA8578101A1 (es) * | 2002-08-13 | 2004-05-07 | Warner Lambert Co | Derivados de heterobiarilo como inhibidores de metaloproteinasa de la matriz |
| AU2003249531A1 (en) | 2002-08-13 | 2004-02-25 | Warner-Lambert Company Llc | Azaisoquinoline derivatives as matrix metalloproteinase inhibitors |
| WO2004014354A1 (en) * | 2002-08-13 | 2004-02-19 | Warner-Lambert Company Llc | 1,6-fused uracil derivatives as matrix metalloproteinase inhibitors |
| JP2006501215A (ja) | 2002-08-13 | 2006-01-12 | ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー | マトリックスメタロプロテイナーゼ阻害剤としての単環式誘導体 |
| AU2003249539A1 (en) * | 2002-08-13 | 2004-02-25 | Warner-Lambert Company Llc | Cyclic compounds containing zinc binding groups as matrix metalloproteinase inhibitors |
| WO2004014375A2 (en) | 2002-08-13 | 2004-02-19 | Warner-Lambert Company Llc | Fused bicyclic metalloproteinase inhibitors |
| US20040142950A1 (en) * | 2003-01-17 | 2004-07-22 | Bunker Amy Mae | Amide and ester matrix metalloproteinase inhibitors |
| JP4667384B2 (ja) | 2003-10-07 | 2011-04-13 | レノビス， インコーポレイテッド | イオンチャネルリガンドとしてのアミド誘導体および薬学的組成物、ならびにこれらを使用する方法 |
| US20060247231A1 (en) * | 2003-12-18 | 2006-11-02 | Warner-Lambert Company Llc | Amide and ester matrix metalloproteinase inhibitors |
| TW200529812A (en) | 2003-12-26 | 2005-09-16 | Chugai Pharmaceutical Co Ltd | Benzamide derivatives |
| CA2588633A1 (en) | 2004-12-07 | 2006-06-15 | Toyama Chemical Co., Ltd. | Novel anthranilic acid derivative or salt thereof |
| US7576099B2 (en) | 2005-02-28 | 2009-08-18 | Renovis, Inc. | Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
| FI20085415A0 (fi) * | 2008-05-06 | 2008-05-06 | Raimo Tuominen | Proteiinikinaaseja muuntavia aineita |
| JP5657201B2 (ja) * | 2008-09-30 | 2015-01-21 | サンメディカル株式会社 | 酵素阻害作用または酵素阻害作用と抗菌作用とを有する歯科用組成物 |
| RU2522582C2 (ru) | 2008-11-20 | 2014-07-20 | Панацеа Биотек Лтд. | Новые противомикробные средства |
| US8906913B2 (en) | 2009-06-26 | 2014-12-09 | Panacea Biotec Limited | Azabicyclohexanes |
| CN103012189A (zh) * | 2012-12-20 | 2013-04-03 | 天津理工大学 | 具有抗血小板聚集作用的酰胺类化合物及其制备和应用 |
| CN105693518B (zh) * | 2014-11-28 | 2018-12-14 | 天津耀宇生物技术有限公司 | 从三棱中提取邻苯二甲酸二丁酯的方法及其应用 |
| CN105884620A (zh) * | 2016-04-22 | 2016-08-24 | 东南大学 | 4-羟基-1，3苯二甲酸二酯类衍生物及其制备和应用 |
| CN116769179B (zh) * | 2023-06-21 | 2024-02-06 | 中国科学院沈阳应用生态研究所 | 一种含间苯二甲酸的配位聚合物及其制备方法 |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5425289A (en) | 1993-10-21 | 1995-06-20 | Snap-On Incorporated | Bung tool |
| DE3931432A1 (de) | 1989-09-21 | 1991-04-04 | Hoechst Ag | Pyrimidin-4,6-dicarbonsaeurediamide, verfahren zu deren herstellung sowie verwendung derselben sowie arzneimittel auf basis dieser verbindungen |
| US5260323A (en) | 1990-06-28 | 1993-11-09 | Hoechst Aktiengesellschaft | 2,4- and 2,5-substituted pyridine-N-oxides, processes for their preparation and their use |
| DE4020570A1 (de) | 1990-06-28 | 1992-01-02 | Hoechst Ag | 2,4- und 2,5-substituierte pyridin-n-oxide, verfahren zu deren herstellung sowie deren verwendung |
| EP0541042A1 (de) | 1991-11-05 | 1993-05-12 | Hoechst Aktiengesellschaft | Pyridin-2,4- und 2,5-dicarbonsäureamide und deren Derivate, Verfahren zu ihrer Herstellung sowie deren Verwendung als Arzneimittel |
| JPH05193260A (ja) * | 1992-01-20 | 1993-08-03 | Mitsubishi Paper Mills Ltd | 感熱記録材料 |
| US6008243A (en) | 1996-10-24 | 1999-12-28 | Agouron Pharmaceuticals, Inc. | Metalloproteinase inhibitors, pharmaceutical compositions containing them, and their use |
| KR20000057444A (ko) | 1996-12-09 | 2000-09-15 | 로즈 암스트롱, 크리스틴 에이. 트러트웨인 | 심기능부전 및 심실확장의 치료 및 예방 방법 |
| WO1999005148A1 (en) * | 1997-07-24 | 1999-02-04 | University Of Kentucky Research Foundation | Phosphonated agents and their antiangiogenic and antitumorigenic use |
| JPH11199512A (ja) | 1997-10-24 | 1999-07-27 | Pfizer Prod Inc | 変形性関節症および他のｍｍｐ媒介疾患の治療のためのｍｍｐ−１３選択的阻害剤の使用 |
| UA59453C2 (uk) | 1998-08-12 | 2003-09-15 | Пфайзер Продактс Інк. | Похідні гідроксипіпеколат гідроксамової кислоти як інгібітори матричних металопротеїназ |
| WO2001005389A2 (en) * | 1999-07-16 | 2001-01-25 | G.D. Searle & Co. | N-sulfonylaminiacid derivatives as inhibitors of metalloprteinase |
| PA8498701A1 (es) | 1999-08-12 | 2002-08-26 | Pfizer Prod Inc | Pirimidina-2,4,6-trionas inhibidores de metaloproteinasas |
| US6934639B1 (en) | 2000-02-25 | 2005-08-23 | Wyeth | Methods for designing agents that interact with MMP-13 |
| EP1138680A1 (en) | 2000-03-29 | 2001-10-04 | Pfizer Products Inc. | Gem substituted sulfonyl hydroxamic acids as MMP inhibitors |
| PL362919A1 (en) | 2000-10-26 | 2004-11-02 | Pfizer Products Inc. | Pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| CA2425283A1 (en) | 2000-10-26 | 2002-05-02 | Pfizer Products Inc. | Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| DE10105926B4 (de) | 2001-02-09 | 2005-06-16 | Koenig & Bauer Ag | Rollenrotationsdruckmaschine |
| JP4531996B2 (ja) | 2001-02-09 | 2010-08-25 | 株式会社エー・エム・ティー・研究所 | ポリイミドフィルム積層体 |
| ATE472535T1 (de) | 2001-02-14 | 2010-07-15 | Warner Lambert Co | Pyrimidinmatrixmetalloproteinaseinhibitoren |
| DOP2002000332A (es) | 2001-02-14 | 2002-08-30 | Warner Lambert Co | Inhibidores de piridina de metaloproteinasas de la matriz |
| DOP2002000333A (es) * | 2001-02-14 | 2002-09-30 | Warner Lambert Co | Derivados de acido isoftalico como inhibidores de metaloproteinasas de la matriz |
| US6933298B2 (en) | 2001-12-08 | 2005-08-23 | Aventis Pharma Deutschland Gmbh | Pyridine-2,4-dicarboxylic acid diamides and pyrimidine-4,6-dicarboxylic acid diamides and the use thereof for selectively inhibiting collagenases |
| DE10160357A1 (de) | 2001-12-08 | 2003-06-18 | Aventis Pharma Gmbh | Verwendung von Pyridin-2,4-dicarbonsäurediamiden und Pyrimidin-4,6-dicarbonsäurediamiden zur selektiven Inhibierung von Kollagenasen |
-
2002
- 2002-01-24 DO DO2002000333A patent/DOP2002000333A/es unknown
- 2002-02-04 CA CA002435376A patent/CA2435376A1/en not_active Abandoned
- 2002-02-04 WO PCT/IB2002/000344 patent/WO2002064547A2/en not_active Ceased
- 2002-02-04 MX MXPA03006598A patent/MXPA03006598A/es active IP Right Grant
- 2002-02-04 EP EP02716262A patent/EP1362028A2/en not_active Withdrawn
- 2002-02-04 BR BR0207201-7A patent/BR0207201A/pt not_active IP Right Cessation
- 2002-02-04 JP JP2002564480A patent/JP2005503327A/ja active Pending
- 2002-02-11 PE PE2002000100A patent/PE20020859A1/es not_active Application Discontinuation
- 2002-02-13 TN TNTNSN02008A patent/TNSN02008A1/fr unknown
- 2002-02-13 US US10/075,918 patent/US6995151B2/en not_active Expired - Fee Related
- 2002-02-13 AR ARP020100479A patent/AR032679A1/es not_active Application Discontinuation
- 2002-02-13 UY UY27169A patent/UY27169A1/es not_active Application Discontinuation
- 2002-02-14 PA PA20028539801A patent/PA8539801A1/es unknown
-
2005
- 2005-09-29 US US11/238,502 patent/US7214712B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005503327A5 (enExample) | ||
| JP3231042B2 (ja) | ２−（２，６−ジ−ハロ−フェニルアミノ）フェニル酢酸の誘導体の硝酸エステルおよびその製造法 | |
| DE60008369T2 (de) | N-cyanomethylamide als protease-inhibitoren | |
| JP2510839B2 (ja) | 薬剤における第一級及び第二級アミン官能基のための生物変換性プロドラッグ成分として有用な新規なｎ−（アシルオキシ−アルコキシ）カルボニル誘導体類の新規な製造方法 | |
| EP0600949B1 (de) | Neue 3,5-di-tert.butyl-4-hydroxyphenyl-derivate, verfahren zu ihrer herstellung und arzneimittel | |
| CN104011040B (zh) | 2‑氧代‑1,3‑二氧戊环‑4‑甲酰胺、其制备方法和用途 | |
| PT1430020E (pt) | Sais de amónio quaternário de omega-aminoalquilamidas de ácidos r-2-arilpropiónicos e composições farmacêuticas que os contêm | |
| JPH04235149A (ja) | アシル化合物 | |
| JP2008511601A5 (enExample) | ||
| EP1701946A2 (fr) | Derives de 1-piperazine- et 1-homopiperazine-carboxylates, leur preparation et leur application en tant qu'inhibiteurs de l'enzyme faah | |
| DE69132167T2 (de) | Kondensierte benzoxa-ringverbindung, deren herstellung sowie diese enthaltendes arzneimittel | |
| CA1086735A (en) | Piperidino-quinazolines | |
| DE3830054A1 (de) | Phenylamide - verfahren zu ihrer herstellung sowie diese verbindungen enthaltende arzneimittel | |
| EP0239907B1 (de) | Neue Phenoxyalkylcarbonsäure-Derivate, Verfahren zu ihrer Herstellung, sowie diese Verbindungen enthaltende Arzneimittel | |
| MXPA04012783A (es) | Derivados de aminoalcohol. | |
| JP4822351B2 (ja) | アリールアルキルカルバメート誘導体、それらの製造方法および治療用途 | |
| GB2044760A (en) | Guanidinobenzoic acid derivatives | |
| DE60316683T2 (de) | Phenylcyclohexylpropanolaminderivate, deren herstellung und therapeutsche anwendung | |
| US5191119A (en) | Process for producing non-ionic radiographic contrast media utilizing N-allylation | |
| US4083992A (en) | Alkanolamine derivatives | |
| JPH08268983A (ja) | 中間体として有用なアニリン誘導体 | |
| CN101939289A (zh) | 用于制备伏立诺他的新方法 | |
| CA1109077A (en) | 2-hydrazonopropionic acid derivatives and the preparation thereof | |
| JP4097291B2 (ja) | 置換バリンアミド誘導体の製造方法 | |
| US4131685A (en) | Pharmaceutical compositions and uses of alkanolamine derivatives |